Pharmacia
This article was originally published in The Tan Sheet
Executive Summary
Rogaine first quarter sales reached $24 mil. in the U.S., a 27% increase, and $32 mil. worldwide, up 24%, the company reports April 25. Pharmacia adds it is still in discussions with FDA regarding an over-the-counter women's extra strength hair regrowth product containing 5% minoxidil; the firm markets a 5% minoxidil OTC product for men. Global revenues from the Nicorette smoking cessation gum declined 9% to $55 mil. Overall, Pharmacia's sales totaled $4.29 bil., up 4.7%, while net income dropped 71.5% to $98 mil. due, in part, to roughly $460 mil. in costs related to the merger with Monsanto
You may also be interested in...
Supplement GMP Warning Letters Make Modest Debut In 2010
Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC
In Brief
Combe sells most of its OTC brands
People In Brief
Perrigo promotes in pricing, planning